Rene Figueredo
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Journal: Nature medicine
Published: February 09, 2023
IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 08, 2022
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: September 07, 2022
Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 02, 2022
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity.
Journal: European journal of immunology
Published: July 15, 2019
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2016
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2.
Journal: Oncotarget
Published: February 09, 2016
Last Updated: 09/26/2026